Pomalidomide(pomalyst) 4MG cap
Ended Awarded Last action
- Contract number
- 36C24526N0430
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,422
Award facts
- Contract value 100% obligated
- $16,421.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $16,421.95 for the supply of Pomalidomide (Pomalyst) 4mg capsules to support the Department of Veterans Affairs' Veterans Integrated Service Network 5, with a completion date of March 25, 2026. This firm fixed-price delivery order is issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, a multiple-award indefinite delivery/indefinite quantity vehicle with the VA that carries a ceiling value of $12.3 billion and extends through April 30, 2029. The contract carries no set-aside designations, reflecting Bristol-Myers Squibb's status as a large pharmaceutical manufacturer. Performance of the work will be conducted at the company's Lawrenceville, New Jersey facility, with delivery to Memphis, Tennessee.
This delivery order supports the VA's mission to provide advanced oncology and specialized pharmaceutical therapies to eligible veterans. Pomalidomide is a specialty oncology pharmaceutical used in the treatment of hematologic malignancies, consistent with Bristol-Myers Squibb's primary focus as a federal contractor supplying innovative cancer treatments and immunotherapy products to the Veterans Health Administration. The company has received numerous delivery orders across multiple Veterans Integrated Service Networks since 2022, demonstrating sustained demand for its specialized pharmaceutical portfolio within the VA healthcare system.
Quick answers
Who was awarded contract 36C24526N0430?
36C24526N0430 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 20, 2026.
How much is contract 36C24526N0430 worth?
The government has obligated $16,422 on 36C24526N0430.
Is contract 36C24526N0430 an order under another contract?
Yes. 36C24526N0430 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0430 competed?
The extent of competition for 36C24526N0430 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award